XmAb27564
Xencor
['$xncr', 'xencor']
xencor presents clinical results from phase 1a study of xmab 564 at the eular 2023 congress - health stocks hub $xncr 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2